Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Deep Technology Startup ADGS Releases PANDEXIT, a COVID Variant Simulator Awarded by World Innovation Summit for Health

PANDEXIT simulates the spreading of emerging virus variants and discovers the best policies to protect the population and the economy.


News provided by

ADGS

Jan 27, 2021, 11:55 ET

Share this article

Share toX

Share this article

Share toX

Members of ADGS team: Eng. Nahuel Gonzalez, Eng. Hector Oviedo and Christophe Billiottet
Members of ADGS team: Eng. Nahuel Gonzalez, Eng. Hector Oviedo and Christophe Billiottet

DOHA, Qatar, Jan. 27, 2021 /PRNewswire-PRWeb/ -- A first of its kind software to fight the spread and impact of COVID-19, PANDEXIT, has just been released by Qatar-based Deep Technology startup, ADGS. "By simulating as realistically as possible the social interactions in a specific country, PANDEXIT can extrapolate the spreading of emerging biological diseases and thereby provide a powerful predictive tool to combat the current pandemic," says ADGS CEO, Christophe Billiottet.

"Governments are mostly blind in their fight against the COVID-19 pandemic. Facing a mutating virus, decision makers quickly establish lockdowns or curfews without a real foresight about their effect on the pandemic : there is an unwitting blindness about if containment rules will be efficient or overkill, about how many ICU will be required, when or how regular hospital operations will be affected etc... Things will even be more confusing when only part of the population will be vaccinated. It is absolutely critical to understand and visualize the impact of these decisions on a population and an economy before it occurs..." says Billiottet.

PANDEXIT is a unique predictive system that simulates the broad social network of a country so that once virus hot spots are known experts can develop models of how, when, and where people are likely to move, interact, and get infected.

Post this

PANDEXIT sorts and solves these complex equations using mathematical modelling of infectious diseases.

Using in-house Agent-Based Modelling algorithms developed during years of R&D, PANDEXIT goes much deeper into the complexity of human experiences than current models. It is a unique predictive system that simulates the broad social network of a country so that once virus hot spots are known experts can develop models of how, when, and where people are likely to move, interact, and get infected. "We created this leading technology with a strict respect of data privacy" says Billiottet.

PANDEXIT clearly shows the asymptomatic cases that drive the pandemic, the numbers of victims that should be expected in specific communities... it also adapts to virus mutations or simulates mass vaccinations.

With insights gained from PANDEXIT, organizations fighting the pandemic can test policies, procedures, and protocols, and then shift resources, as necessary, to more effectively slow the pandemic's spread, save lives, and protect the economy. PANDEXIT helps decision makers evaluate the outcome of multiple COVID-19 policies through a reasonable estimation of how the pandemic will evolve under several potential scenarios.

PANDEXIT was awarded by the World Innovation Summit for Health (WISH) in 2020 as one of the fifteen most promising worldwide health innovations.

In October 2020, PANDEXIT models were built and tested for Australia, Singapore, Argentina and Qatar. Forty-day predictive data was very close to the actual pandemic evolution in these countries, displaying sometimes unexpected results that later proved to be accurate, contradicting classic models.

PANDEXIT could be the missing tool in the COVID-19 crisis by providing critical information and predictive analysis with a much higher granularity than statistical models.

The distinctive aspects of PANDEXIT include:

  • It uses innovative agent-based modelling algorithms for computers to reproduce and analyze human behavior. It builds a virtual country, identical to the real one, with its cities, transportation systems, plants, offices, universities, population density, age distribution, medical preconditions, communities etc… and runs simulations on it.
  • Its algorithms are powerful enough to reproduce the massively complex social dynamics of the entire population of a country.
  • It uses ethical data to simulate the propagation of infectious disease throughout the population, using a high number of variable parameters.

About ADGS:

ADGS is the very first Deep Technology startup of Qatar, founded in 2015 by a Qatari businessman, a French entrepreneur, and a team of brilliant international scientists. ADGS conducts R&D to create cutting edge algorithms and build futuristic applications. Specifically, ADGS focuses is in the fields of Agent-Based Modelling (Emergent Behavior), Behavioral Biometrics applied to Cybersecurity, Social Dynamics, Natural Language Processing and Big Data analysis using Artificial Intelligence. ADGS raised 2 million USD through private funding and the Qatar Foundation.

Media Contact

Christophe Billiottet, ADGS, 974 66954090, [email protected]

SOURCE ADGS

Related Links

https://www.adgs.com/

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.